Anti-inflammatory effect of semaglutide: updated systematic review and meta-analysis.

Back

ESC Premium Access

Anti-inflammatory effect of semaglutide: updated systematic review and meta-analysis.

Session: Obesity, weight loss, and cardiovascular disease

Topic: Metabolic Syndrome, Insulin, Insulin Resistance

Speaker: Doctor L. Lobo (Buenos Aires, AR)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Doctor Lorenzo Martin Lobo

Campo de Mayo Military Hospital, Buenos Aires (Argentina)

0 follower

8 more presentations in this session

Effects of glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors and their combination on mitochondrial-derived peptide-c and on markers of neurohumoral activation

Speaker: Doctor I. Ikonomidis (Athens, GR)

Effects of SGLT-2i and GLP-1RA in vascular function parameters: the impact of the weight loss

Speaker: Doctor P. Stampouloglou (Athens, GR)

Association of obesity and metabolic health status with cerebral small vessel disease in stroke-free individuals

Speaker: Associate Professor A. ishida (Okinawa, JP)

Parallel improvement of arterial stiffness with weight loss following intensification of antidiabetic treatment

Speaker: Doctor E. Bletsa (Zurich, CH)

Sex-biased proteomic regulation in obesity

Speaker: Doctor H. Halland (Bergen, NO)

Access the full session

Obesity, weight loss, and cardiovascular disease

Speakers: Doctor L. Lobo, Doctor I. Ikonomidis, Doctor P. Stampouloglou, Associate Professor A. ishida, Doctor E. Bletsa...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources